Spots Global Cancer Trial Database for Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Official Title: Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections
Study ID: NCT02519140
Interventions
Study Description
Brief Summary: This is a study to determine how the viscosity (thickness) of an FDA approved gel affects the ease in which endoscopic mucosal resections (EMR) can be performed.
Detailed Description: This is a study to determine how the viscosity (thickness) of an FDA approved gel made by Cook medical affects the ease in which endoscopic mucosal resections (EMR) - a type of endoscopic surgery performed for localised cancer - can be performed when the gel is injected submucosally. The lifting characteristics of the gel will be assessed by height and diameter and ease with which the subsequent EMR dissection can be performed. These characteristics would be assessed on excised human stomachs and colon, which are harvested during routine sleeve gastrectomy surgeries or colectomies, in an ex-vivo manner.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Maimonides Medical Center, Brooklyn, New York, United States
Contact Details
Name: Danny Sherwinter, MD
Affiliation: Maimonides Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
